PATENT CLAIM ANALYSIS

Application Number: 16012992
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "001890"]

Abstract:
Described are assay methods, modules and kits useful in the detection, treatment and/or prevention of dementia and related conditions, including but not limited to Alzheimer's disease and mild cognitive disorders.

Claim (Index 7):
A method for monitoring the disease progression of and/or efficacy of a treatment regimen for Alzheimer's-related dementia in a patient, said method comprising (a) obtaining two or more test samples from a patient undergoing said treatment regimen for Alzheimer's-related dementia, wherein said two or more test samples include (i) a first test sample obtained from said patient at time t and (ii) at least one additional test sample obtained at time (t+n), wherein n is an integer greater than 1; (b) measuring the level(s) of a first biomarker in said two or more test samples, wherein said first biomarker comprises A\u03b2 16, A\u03b2 17, or combinations thereof; and (c) determining from said level(s) of said first biomarker the progression of and/or efficacy of said treatment regimen in said patient.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 94.0
- Lexical Diversity: 1.12903
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12867479', '12799484', '13874052', '14200020', '10982545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6849848397466889
- 35 USC 102 Novelty (BERT): 0.506116272668536
- Combined Prediction Score: 0.6670979830388737
- Mean Citation Score: 253.80111
- Max Citation Score: 263.87994
- Similarity Product: 202.59518312647103

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test